Accessibility Menu
Sanofi logo

Sanofi(NASDAQ) SNY

Current Price$43.34
Market Cap$104.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)+178%
5 Year+3%
1 Year-9%
1 Month+5%
Sanofi last closing stock price
MetricPriceDate
Last closeUSD 43.352026-07-24
Sanofi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.93%USD 44.662026-07-17
1 month+4.89%USD 41.332026-06-24
3 month-2.2%USD 44.322026-04-24
Year to date-5.59%USD 45.922025-12-31
1 year-8.73%USD 47.502025-07-24
3 year-7.41%USD 46.822023-07-25
5 year+3.3%USD 41.962021-07-23
Since inception+178.26%USD 15.582002-07-01

Sanofi Financials at a Glance

Market Cap

$104.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€47.35B

Net Income (TTM)

€7.56B

EPS (TTM)

$2.39

P/E Ratio

18.08

Dividend

$2.42

Beta (Volatility)

0.33 (Low)

Price

$43.34

Volume

131,012

Open

$43.17

Previous Close

$43.34

Daily Range

$42.97 - $43.48

52-Week Range

$40.89 - $52.68

Estimated Earnings Date

Jul 30, 2026

SNY News

Investor pointing at a chart.

Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows

David Jagielski, CPAJun 30, 2026
Woman using gloves to hold up and inspect a red pill.

Biotech vs. Pharma: What's the Difference?

Keith SpeightsJun 14, 2026
A team of scientists reviewing results in a lab.

1 Dirt Cheap Growth Stock to Buy Right Now

David Jagielski, CPAMay 18, 2026
bundle bills rolled and kept together with a rubber band sit on a table

What Is Price Elasticity of Demand?

Lee SamahaOct 13, 2025
GettyImages-1263079549.jpg

What Is Elasticity in Finance?

Motley Fool StaffApr 17, 2025
Child receiving a vaccination shot from a healthcare professional

Why Sanofi Stock Flew Higher on Friday

Eric VolkmanOct 25, 2024
Patient and physician smiling during a visit

Why Sanofi Stock Was Robustly Healthy Today

Eric VolkmanSep 3, 2024
GettyImages-487041745-drug

Sanofi's New Drug Could Help Deliver a Big Payday

Joseph WilbornMay 8, 2024
Page 1

SNY: Motley Fool Moneyball Superscore

75

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanofi

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Products and Services
  • Specialized therapies for complex conditions like multiple sclerosis and oncology
  • Extensive vaccine portfolio including pediatric and adult immunizations
  • Over-the-counter products for allergies, pain management, and wellness
Growth Outlook
  • Strong pipeline with numerous products in various research stages
  • Collaboration with GlaxoSmithKline on a recombinant Covid-19 vaccine
  • Partnership with Stanford University to advance immunology research
Financial Highlights
  • Q1 2026 revenue of €11.24 billion, reflecting robust demand
  • Trailing twelve months (TTM) net profit margin of 15.95%
  • Dividend yield of 5.33%, indicating strong shareholder returns
Sanofi's diverse product offerings and strategic partnerships position the company for continued growth in the pharmaceutical sector. The recent quarterly revenue demonstrates resilience and demand for its therapeutic solutions. With a solid pipeline and collaborations aimed at innovation, Sanofi is well-equipped to navigate the evolving healthcare landscape. The company's commitment to research and development, alongside a strong financial performance, makes it an attractive option for potential investors.
AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

76,493

CEO

Paul Hudson

Website

www.sanofi.com

Headquarters

Paris, IF 75008, FR

SNY Financials

Key Financial Metrics (TTM)

Gross Margin

71.92%

Operating Margin

19.84%

Net Income Margin

15.95%

Return on Equity

10.51%

Return on Capital

10.47%

Return on Assets

5.90%

Earnings Yield

5.53%

Dividend Yield

5.58%

Payout Ratio

63.16%

Stock Overview

Market Cap

$104.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.40B

Volume

131.01K

Avg. Volume

3.23M

Financials (TTM)

Gross Profit

€34.18B

Operating Income

€6.33B

EBITDA

€12.63B

Operating Cash Flow

€8.88B

Capital Expenditure

-€1.01B

Free Cash Flow

€7.87B

Cash & ST Invst.

€5.54B

Total Debt

€20.02B

Sanofi Performance Analysis

Sanofi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 45,188,742,6911.2%
20232023-12-31EUR 40,884,548,758-9.5%
20242024-12-31EUR 44,436,937,9608.7%
20252025-12-31EUR 49,235,341,67210.8%
Sanofi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301.2%
Q32025-09-3022.7%
Q42025-12-31-7.3%
Q12026-03-31-7.9%
Sanofi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.5019.7%
20232023-12-31EUR 2.32-33.6%
20242024-12-31EUR 2.393.0%
20252025-12-31EUR 2.400.1%
Sanofi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30109.9%
Q32025-09-30-28.8%
Q42025-12-31-229.1%
Q12026-03-31145.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€11.24B

+6.0%

Gross Profit

€8.11B

+5.0%

Gross Margin

72.09%

N/A

Market Cap

$104.25BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.26M

N/A

Employees

82,878

N/A

Net Income

€1.61B

-13.8%

EBITDA

€2.72B

-1.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€5.54B

-30.6%

Total Debt

€20.02B

-4.9%

Accounts Receivable

€482.00M

+7.8%

Inventory

€23.50B

+7.6%

Long Term Debt

€13.84B

+3.2%

Short Term Debt

€6.18B

-19.1%

Return on Assets

5.90%

N/A

Return on Invested Capital

9.59%

N/A

Free Cash Flow

€1.68B

-19.6%

Operating Cash Flow

€1.68B

-19.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSKGSK plc
$51.35+1.20%
MDTMedtronic plc
$83.21+1.46%
VRTXVertex Pharmaceuticals Incorporated
$477.36+0.90%
HCAHCA Healthcare, Inc.
$382.19+1.51%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About SNY

What is the current price of Sanofi?

Sanofi is trading at $43.34 per share.

What is the 52-week range for Sanofi?

Over the past 52 weeks, Sanofi has traded between $40.89 and $52.68.

How much debt does Sanofi have?

As of the most recent reporting period, Sanofi reported total debt of €23.88B.

How much cash does Sanofi have on hand?

Sanofi reported €8.68B in cash and cash equivalents in its most recent financial results.

What is Sanofi’s dividend yield?

Sanofi currently has a dividend yield of 5.58%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services